1. Home
  2. RNXT vs OPAL Comparison

RNXT vs OPAL Comparison

Compare RNXT & OPAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • OPAL
  • Stock Information
  • Founded
  • RNXT 2012
  • OPAL 1998
  • Country
  • RNXT United States
  • OPAL United States
  • Employees
  • RNXT N/A
  • OPAL N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • OPAL Natural Gas Distribution
  • Sector
  • RNXT Health Care
  • OPAL Utilities
  • Exchange
  • RNXT Nasdaq
  • OPAL Nasdaq
  • Market Cap
  • RNXT 37.6M
  • OPAL 39.8M
  • IPO Year
  • RNXT 2021
  • OPAL N/A
  • Fundamental
  • Price
  • RNXT $1.06
  • OPAL $2.29
  • Analyst Decision
  • RNXT Strong Buy
  • OPAL Buy
  • Analyst Count
  • RNXT 2
  • OPAL 4
  • Target Price
  • RNXT $7.00
  • OPAL $4.75
  • AVG Volume (30 Days)
  • RNXT 116.6K
  • OPAL 126.5K
  • Earning Date
  • RNXT 05-15-2025
  • OPAL 05-08-2025
  • Dividend Yield
  • RNXT N/A
  • OPAL N/A
  • EPS Growth
  • RNXT N/A
  • OPAL N/A
  • EPS
  • RNXT N/A
  • OPAL 0.02
  • Revenue
  • RNXT $43,000.00
  • OPAL $320,427,000.00
  • Revenue This Year
  • RNXT $4,755.81
  • OPAL $28.13
  • Revenue Next Year
  • RNXT $187.93
  • OPAL $18.02
  • P/E Ratio
  • RNXT N/A
  • OPAL $116.61
  • Revenue Growth
  • RNXT N/A
  • OPAL 15.22
  • 52 Week Low
  • RNXT $0.75
  • OPAL $1.26
  • 52 Week High
  • RNXT $1.69
  • OPAL $5.18
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 60.35
  • OPAL 74.30
  • Support Level
  • RNXT $1.02
  • OPAL $1.65
  • Resistance Level
  • RNXT $1.09
  • OPAL $2.54
  • Average True Range (ATR)
  • RNXT 0.05
  • OPAL 0.15
  • MACD
  • RNXT 0.01
  • OPAL 0.12
  • Stochastic Oscillator
  • RNXT 80.00
  • OPAL 85.48

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

Share on Social Networks: